Isabelle Van Praagh Selected Research

VEP protocol

4/2005

Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Van Praagh Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 10/2018 - 01/2002
3	Neoplasms (Cancer) 01/2021 - 01/2004
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Weight Loss (Weight Reduction) 10/2018
1	Inflammatory Breast Neoplasms 11/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2004

Drug/Important Bio-Agent (IBA)

4	Epirubicin (Ellence)FDA LinkGeneric 04/2005 - 01/2002
3	Vinorelbine (Navelbine)FDA LinkGeneric 11/2006 - 01/2002
2	Taxoids (Taxanes)IBA 10/2018 - 11/2006
2	exemestane (Aromasin)FDA Link 01/2015 - 06/2009
2	Aromatase InhibitorsIBA 01/2015 - 06/2009
2	Tamoxifen FDA LinkGeneric 06/2009 - 12/2004
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	CurcuminIBA 01/2021
1	Everolimus FDA Link 01/2015
1	Hormones (Hormone)IBA 01/2015
1	Letrozole (Femara)FDA LinkGeneric 06/2009
1	Anastrozole (Arimidex)FDA LinkGeneric 06/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2005
1	Fluorouracil (Carac)FDA LinkGeneric 08/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2004
1	Serine (L-Serine)FDA Link 01/2004
1	Amino Acids FDA Link 01/2004
1	Glutamic Acid (Glutamate)FDA Link 01/2004
1	Indicators and Reagents (Reagents)IBA 04/2002
1	Methotrexate (Mexate)FDA LinkGeneric 01/2002

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 10/2018 - 01/2002
4	Therapeutics 01/2021 - 08/2004
4	Neoadjuvant Therapy 11/2006 - 01/2002
3	Adjuvant Chemotherapy 10/2018 - 08/2004
2	Induction Chemotherapy 11/2006 - 04/2002
1	Castration 01/2021
1	Radiotherapy 11/2006
1	VEP protocol 04/2005